REQUEST A DEMO
Total
USD $0.00
Search more companies

"Polfarmex" S.A. (Poland)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: "Polfarmex" S.A. Profile Updated: October 10, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Polfarmex S.A. is a recognized manufacturer of generic drugs. With 30 years of experience in the Polish market, the company has gained the trust of patients, doctors, and contractors. Their products are available in the markets of Central and Eastern Europe, the Baltic states, and the Far East. The company specializes in the production of prescription generic drugs in the fields of pulmonology, cardiology, gastroenterology, neurology, dermatology, and gynecology. They also offer a wide range of over-the-counter drugs, dietary supplements, and cosmetics. Their portfolio consists of over 100 products and is continuously expanding.

Headquarters
Ul. Jozefow 9
Kutno; Lodzkie; Postal Code: 99-300

Contact Details: Purchase the "Polfarmex" S.A. report to view the information.

Website: http://polfarmex.pl

Basic Information
Total Employees:
Purchase the "Polfarmex" S.A. report to view the information.
Outstanding Shares:
Purchase the "Polfarmex" S.A. report to view the information.
Registered Capital:
Purchase the "Polfarmex" S.A. report to view the information.
Financial Auditors:
Purchase the "Polfarmex" S.A. report to view the information.
Incorporation Date:
April 20, 2004
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Subsidiaries
Polfarmex Ip Sp. z o.o.
100%
Polcars Sp. z o.o.
95%
Osrodek Badan Farmaceutycznych I Klinicznych "Biofana" Sp. z o.o.
65.63%
Company Performance
Financial values in the chart are available after "Polfarmex" S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
13.46%
Total operating revenue
17.61%
Operating profit (EBIT)
55.97%
EBITDA
20.67%
Net Profit (Loss) for the Period
-37.98%
Total assets
-1.35%
Total equity
3.78%
Operating Profit Margin (ROS)
1.97%
Net Profit Margin
-4.16%
Return on Equity (ROE)
-3.78%
Debt to Equity Ratio
-6.45%
Quick Ratio
-0.49%
Cash Ratio
-0.25%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?